Main > ENDOCRINOLOGY > JP. F. Hyperuricemia>Treat.>Urate>

---

JP. F. Hyperuricemia>Treat.>Urate>'s subsections
(*) JP Approval Date: 2020. 01
>Transporter Inhibitor Tablet
Company
Company Licensee CA; EU; UK & USA
Generic Name: Dotinurad
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 12.07
PR Web-Site
RTM

JP. F. Hyperuricemia>Treat.>Urate>'s products
This section has no products